Does ALIROCUMAB Cause Bladder cancer? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Bladder cancer have been filed in association with ALIROCUMAB (Praluent). This represents 0.0% of all adverse event reports for ALIROCUMAB.
7
Reports of Bladder cancer with ALIROCUMAB
0.0%
of all ALIROCUMAB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Bladder cancer From ALIROCUMAB?
Of the 7 reports, 1 (14.3%) resulted in death, 2 (28.6%) required hospitalization.
Is Bladder cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Bladder cancer?
RANITIDINE (41,984)
PIOGLITAZONE (7,295)
METFORMIN\PIOGLITAZONE (278)
ADALIMUMAB (268)
ETANERCEPT (225)
METHOTREXATE (179)
INFLIXIMAB (165)
APIXABAN (159)
VALSARTAN (144)
LENALIDOMIDE (120)
Which ALIROCUMAB Alternatives Have Lower Bladder cancer Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN